Evotec SE (EVO) Tax Provisions (2009 - 2025)
Evotec SE's (EVO) quarterly Tax Provisions came in at -$17.3 million in Q4 2025, up 35.27% year-over-year from -$12.8 million in Q4 2024, and down 11534.95% quarter-over-quarter from -$148470.0 in Q3 2025.
Analysis
Evotec SE (EVO) Tax Provisions (2009 - 2025) Analysis & Trends
Evotec SE has disclosed Tax Provisions across 9 years of filings, most recently posting -$17.3 million for Q4 2025.
- In Q4 2025, Tax Provisions rose 35.27% year-over-year to -$17.3 million; the TTM figure through Dec 2025 stood at -$45.9 million (down 1174.38% YoY), while the FY2025 annual figure was -$18.9 million, down 731.86% from the prior year.
- Tax Provisions came in at -$17.3 million for Q4 2025 at Evotec SE, down from -$148470.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $8.5 million in Q4 2023 to a low of -$33.8 million in Q4 2021.
- Average Tax Provisions over 5 years is -$4.0 million, with a median of -$1.3 million recorded in 2021.
- Year-over-year, Tax Provisions surged 102562.97% in 2023 and plunged 414.17% in 2024.
- Over 5 years, Tax Provisions stood at -$33.8 million in 2021, then surged by 100.02% to $8274.2 in 2022, then surged by 102562.97% to $8.5 million in 2023, then sank by 414.17% to -$26.7 million in 2024, then soared by 35.27% to -$17.3 million in 2025.
- Per Business Quant data, the three most recent Tax Provisions figures were -$17.3 million in Q4 2025, -$148470.0 in Q3 2025, and -$1.8 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 60.00 Mn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 30.30 Mn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 53.93 Mn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | -19.62 Mn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | 12.00 Mn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | 128,000.00 |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | 172,000.00 |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | 267,728.71 |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | 3,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -17.27 Mn |
| Sep 30, 2025 | -148,470.00 |
| Mar 31, 2025 | -1.82 Mn |
| Dec 31, 2024 | -26.69 Mn |
| Sep 30, 2024 | 7.95 Mn |
| Mar 31, 2024 | 6.64 Mn |
| Dec 31, 2023 | 8.49 Mn |
| Aug 29, 2023 | 2,367.73 |
| Jun 30, 2023 | -8.37 Mn |
| Dec 31, 2022 | 8,274.21 |
| Sep 30, 2022 | 3.94 Mn |
| Jun 30, 2022 | -3.84 Mn |
| Mar 31, 2022 | -4.27 Mn |
| Dec 31, 2021 | -33.78 Mn |
| Sep 30, 2021 | 5.46 Mn |
| Jun 30, 2021 | -1.25 Mn |
| Mar 31, 2021 | -2.89 Mn |
| Dec 31, 2020 | -26.79 Mn |
| Sep 30, 2020 | 6.98 Mn |
| Dec 31, 2019 | -13.78 Mn |